Rechercher

OncoDNA’s Precision Medicine Solutions Available from Two Major Healthcare Providers in the UK

July 2018

Our portfolio's company, OncoDNA , the healthcare technology company making precision medicine a reality, announced in July 2018 that it will supply the Company’s range of world-class diagnostic cancer tests to two leading UK healthcare providers, Nuffield Health (“Nuffield”) and BMI Healthcare (“BMI”), via agreements signed by OncoDNA’s UK distributor, Everything Genetic Ltd (“Everything Genetic”).


Please find the press release here.

www.oncodna.com

  • Facebook - Gris Cercle
  • Twitter - Gris Cercle
  • LinkedIn - Gris Cercle

Inventures Investment Partners S.A. — Place Sainte-Gudule 5, 1000 Brussels, Belgium — +32 472 34 14 32 — info@inventures.fund — BE 0693.960.071

Legal Disclaimer